CIK 0001729427
- Non-accelerated filer
- Smaller reporting company
CNS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CNSP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 822318545
- Phone
- +1 800-946-9185
- Business address
- 2100 WEST LOOP SOUTH, SUITE 900, HOUSTON, TX, 77027
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 27,000 shares at $1.27 ($34,177)
- 4 Open-market buy Chief Executive Officer bought 2,750 shares at $1.80 ($4,945)
- 4/A Derivatives Options or other derivatives
- 4 Planned sale 10% owner sold 94,298 shares at an average $1.41 ($133,114)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Chief Executive Officer acquired 1,250 shares (option exercise)
- 4 Exercise or conversion Chief Financial Officer acquired 521 shares (option exercise)
- 4 Open-market buy Director bought 2,500 shares at $1.70 ($4,250)
- 4 Open-market buy Chief Financial Officer bought 3,100 shares at $3.20 ($9,920)
- 4 Open-market buy Director bought 7,173 shares at $0.74 ($5,308)
- 4 Open-market buy Chief Executive Officer bought 15,000 shares at $0.69 ($10,409)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 5 · 90 filings